Artwork

Content provided by The PJ Pod and Pharmaceutical Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The PJ Pod and Pharmaceutical Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

How can pharmacists best support patients with chronic lymphocytic leukaemia?

30:48
 
Distribuie
 

Manage episode 440763414 series 3329558
Content provided by The PJ Pod and Pharmaceutical Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The PJ Pod and Pharmaceutical Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Over the last decade, the development of targeted therapies has significantly changed the way that chronic lymphocytic leukaemia (CLL) is treated. Survival and life expectancy has improved, and this patient cohort is living and receiving treatment for longer than ever before. These changes have meant that the involvement of pharmacists across all sectors in the treatment of CLL patients has also evolved significantly. In this episode of The PJ Pod, Caitlin Killen, assistant clinical editor, speaks to a patient who has been living with CLL for 17 years, as well as with two pharmacists involved in the care of CLL patients, to understand how pharmacists can best support patients with CLL. Many thanks to expert patient Anthea Holland; Catherine Parbutt, consultant pharmacist for cancer services, The Leeds Teaching Hospitals NHS Trust; and Tejal Gorasia, principal cancer pharmacist, Milton Keynes University Hospital NHS Foundation Trust, for their expertise. This episode was produced by Geoff Marsh.
  continue reading

52 episoade

Artwork
iconDistribuie
 
Manage episode 440763414 series 3329558
Content provided by The PJ Pod and Pharmaceutical Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The PJ Pod and Pharmaceutical Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Over the last decade, the development of targeted therapies has significantly changed the way that chronic lymphocytic leukaemia (CLL) is treated. Survival and life expectancy has improved, and this patient cohort is living and receiving treatment for longer than ever before. These changes have meant that the involvement of pharmacists across all sectors in the treatment of CLL patients has also evolved significantly. In this episode of The PJ Pod, Caitlin Killen, assistant clinical editor, speaks to a patient who has been living with CLL for 17 years, as well as with two pharmacists involved in the care of CLL patients, to understand how pharmacists can best support patients with CLL. Many thanks to expert patient Anthea Holland; Catherine Parbutt, consultant pharmacist for cancer services, The Leeds Teaching Hospitals NHS Trust; and Tejal Gorasia, principal cancer pharmacist, Milton Keynes University Hospital NHS Foundation Trust, for their expertise. This episode was produced by Geoff Marsh.
  continue reading

52 episoade

Toate episoadele

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință

Listen to this show while you explore
Play